Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.
Hypertension
; 79(5): 1122-1131, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35266409
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Deprescriptions
/
Antihypertensive Agents
Type of study:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Hypertension
Year:
2022
Type:
Article